|
1
|
Esteban-Jurado C, Garre P, Vila M, et al:
New genes emerging for colorectal cancer predisposition. World J
Gastroenterol. 20:1961–1971. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gingras D and Beliveau R: Colorectal
cancer prevention through dietary and lifestyle modifications.
Cancer Microenviron. 4:133–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zhang S, et al: Annual
report on status of cancer in China, 2010. Chin J Cancer Res.
26:48–58. 2014.
|
|
4
|
Mao Z, Sun J, Feng B, et al: The
metastasis suppressor, N-myc downregulated gene 1 (NDRG1), is a
prognostic biomarker for human colorectal cancer. PLoS One.
8:e682062013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Popa F, Bratucu M and Radu P: Present and
future tense in operable rectal cancer. Chirurgia (Bucur).
106:11–16. 2011.PubMed/NCBI
|
|
6
|
Cherry LM: The genetic etiology of
familial and nonfamilial colorectal cancer. Proc (Bayl Univ Med
Cent). 24:139–141. 2011.PubMed/NCBI
|
|
7
|
Hwang KE, Park DS, Kim YS, et al: Prx1
modulates the chemosensitivity of lung cancer to docetaxel through
suppression of FOXO1-induced apoptosis. Int J Oncol. 43:72–78.
2013.PubMed/NCBI
|
|
8
|
Fujii J and Ikeda Y: Advance in our
understanding of peroxiredoxin, a multifunctional, mammalian redox
protein. Redox Rep. 7:123–130. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sato Y, Kojima R, Okumura M, et al:
Synergistic cooperation of PDI family members in peroxiredoxin
4-driven oxidative protein folding. Sci Rep. 3:24562013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spinsanti G, Zannolli R, Panti C, et al:
Quantitative real-time PCR detection of TRPV1-4 gene expression in
human leukocytes from healthy and hyposensitive subjects. Mol Pain.
4:512008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie L, Ni WK, Chen XD, et al: The
expressions and clinical significances of tissue and serum
galectin-3 in pancreatic carcinoma. J Cancer Res Clin Oncol.
138:1035–1043. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chae HZ, Robison K, Poole LB, et al:
Cloning and sequencing of thiol-specific antioxidant from mammalian
brain: alkyl hydroperoxide reductase and thiol-specific antioxidant
define a large family of antioxidant enzymes. Proc Natl Acad Sci
USA. 91:7017–7021. 1994. View Article : Google Scholar
|
|
13
|
Tavender TJ and Bulleid NJ: Peroxiredoxin
IV protects cells from oxidative stress by removing
H2O2produced during disulphide formation. J
Cell Sci. 123:2672–2679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schulte J: Peroxiredoxin 4: a
multifunctional biomarker worthy of further exploration. BMC Med.
9:1372011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Parkin DM: The global health burden of
infection-associated cancers in the year 2002. Int J Cancer.
118:3030–3044. 2006.PubMed/NCBI
|
|
16
|
Lovasz BD, Lakatos L, Golovics PA, et al:
Risk of colorectal cancer in Crohn’s disease patients with colonic
involvement and stenosing disease in a population-based cohort from
Hungary. J Gastrointestin Liver Dis. 22:265–268. 2013.
|
|
17
|
Wu Y, Antony S, Hewitt SM, et al:
Functional activity and tumor-specific expression of dual oxidase 2
in pancreatic cancer cells and human malignancies characterized
with a novel monoclonal antibody. Int J Oncol. 42:1229–1238.
2013.
|
|
18
|
Machida K, Chen CL, Liu JC, et al: Cancer
stem cells generated by alcohol, diabetes, and hepatitis C virus. J
Gastroenterol Hepatol. 27(Suppl 2): 19–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karihtala P, Kauppila S, Soini Y and
Arja-Jukkola-Vuorinen: Oxidative stress and counteracting
mechanisms in hormone receptor positive, triple-negative and
basal-like breast carcinomas. BMC Cancer. 11:2622011. View Article : Google Scholar
|
|
20
|
Karihtala P, Soini Y, Vaskivuo L, Bloigu R
and Puistola U: DNA adduct 8-hydroxydeoxyguanosine, a novel
putative marker of prognostic significance in ovarian carcinoma.
Int J Gynecol Cancer. 19:1047–1051. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Basu A, Banerjee H, Rojas H, et al:
Differential expression of peroxiredoxins in prostate cancer:
consistent upregulation of PRDX3 and PRDX4. Prostate. 71:755–765.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang KP, Yu JS, Chien KY, et al:
Identification of PRDX4 and P4HA2 as metastasis-associated proteins
in oral cavity squamous cell carcinoma by comparative tissue
proteomics of microdissected specimens using iTRAQ technology. J
Proteome Res. 10:4935–4947. 2011. View Article : Google Scholar
|
|
23
|
Soini Y, Haapasaari KM, Vaarala MH,
Turpeenniemi-Hujanen T, Karja V and Karihtala P:
8-hydroxydeguanosine and nitrotyrosine are prognostic factors in
urinary bladder carcinoma. Int J Clin Exp Pathol. 4:267–275.
2011.PubMed/NCBI
|
|
24
|
Ishii T, Warabi E and Yanagawa T: Novel
roles of peroxiredoxins in inflammation, cancer and innate
immunity. J Clin Biochem Nutr. 50:91–105. 2012.PubMed/NCBI
|
